|
1
|
Parkin DM, Bray F, Ferlay J, et al: Global
cancer statistics 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Khushalani N: Cancer of the esophagus and
stomach. Mayo Clin Proc. 83:712–722. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim JM, Sohn HY, Yoon SY, et al:
Identification of gastric cancer-related genes using a cDNA
microarray containing novel expressed sequence tags expressed in
gastric cancer cells. Clin Cancer Res. 11:473–482. 2005.PubMed/NCBI
|
|
4
|
Chen X, Leung SY, Yuen ST, et al:
Variation in gene expression patterns in human gastric cancers. Mol
Biol Cell. 14:3208–3215. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pasquinelli AE, Reinhart BJ, Slack F, et
al: Conservation of the sequence and temporal expression of let-7
heterochronic regulatory RNA. Nature. 408:86–89. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Reinhart BJ, Slack FJ, Basson M, et al:
The 21-nucleotide let-7 RNA regulates developmental timing in
Caenorhabditis elegans. Nature. 403:901–906. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li X, Zhang Y, Zhang Y, et al: Survival
prediction of gastric cancer by a seven-microRNA signature. Gut.
59:579–585. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ueda T, Volinia S, Okumura H, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: a microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar
|
|
10
|
Shimono Y, Zabala M, Cho RW, et al:
Downregulation of miRNA-200c links breast cancer stem cells with
normal stem cells. Cell. 138:592–603. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun Y, Fang R, Li C, et al: Hsa-miR-182
suppresses lung tumorigenesis through down regulation of RGS17
expression in vitro. Biochem Biophys Res Commun. 396:501–507. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kong WQ, Bai R, Liu T, et al: MicroRNA-182
targets cAMP-responsive element-binding protein 1 and suppresses
cell growth in human gastric adenocarcinoma. FEBS J. 279:1252–1260.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bacus SS, Zelnick CR, Plowman G, et al:
Expression of the erbB-2 family of growth factor receptors and
their ligands in breast cancers. Implication for tumor biology and
clinical behavior. Am J Clin Pathol. 102(Suppl 1): S13–S24.
1994.PubMed/NCBI
|
|
14
|
Liao XH, Lu DL, Wang N, et al: Estrogen
receptor α mediates proliferation of breast cancer MCF-7 cells via
a p21/PCNA/ E2F1-dependent pathway. FEBS J. 281:927–942. 2014.
View Article : Google Scholar
|
|
15
|
Luo XG, Zou JN, Wang SZ, et al: Novobiocin
decreases SMYD3 expression and inhibits the migration of MDA-MB-231
human breast cancer cells. IUBMB Life. 62:194–199. 2010. View Article : Google Scholar
|
|
16
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Z, Zhan W, Wang Z, et al: Inhibition of
PRL-3 gene expression in gastric cancer cell line SGC7901 via
micoRNA suppressed reduces peritoneal metastasis. Biochem Biophys
Res Commun. 348:229–237. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gao C, Zhan Z, Liu W, et al: Reduced
microRNA-218 expression is associated with high nuclear factor
kappa B activation in gastric cancer. Cancer. 116:41–49. 2010.
|
|
19
|
Gregory RI and Shiekhattar R: MicroRNA
biogenesis and cancer. Cancer Res. 65:3509–3512. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song YX, Yue ZY, Wang ZN, et al:
MicroRNA-148b is frequently down-regulated in gastric cancer and
acts as a tumor suppressor by inhibiting cell proliferation. Mol
Cancer. 10:12011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ding L, Xu Y, Zhang W, et al: miR-375
frequently downregulated in gastric cancer inhibits cell
proliferation by targeting JAK2. Cell Res. 20:784–793. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kaji M, Yonemura Y, Harada S, et al:
Participation of c-met in the progression of human gastric cancers:
anti-c-met oligonucleotides inhibit proliferation or invasiveness
of gastric cancer cells. Cancer Gene Ther. 3:393–404.
1996.PubMed/NCBI
|
|
23
|
Chen GY and Wang DR: The expression and
clinical significance of CD44v in human gastric cancers. World J
Gastroenterol. 6:125–127. 2000.
|
|
24
|
Tamura G, Kihana T, Nomura K, et al:
Detection of frequent p53 gene mutations in primary gastric cancer
by cell sorting and polymerase chain reaction single-strand
conformation polymorphism analysis. Cancer Res. 51:3056–3058.
1991.PubMed/NCBI
|
|
25
|
Horii A, Nakatsuru S, Miyoshi Y, et al:
The APC gene, responsible for familial adenomatous polyposis, is
mutated in human gastric cancer. Cancer Res. 52:3231–3233.
1992.PubMed/NCBI
|
|
26
|
Uchino S, Tsuda H, Noguchi M, et al:
Frequent loss of heterozygosity at the DCC locus in gastric cancer.
Cancer Res. 52:3099–3102. 1992.PubMed/NCBI
|
